Abstract: The simplest possible description of the KBH Vehicle Weight Efficiency Formula might be that of a combination of a weight-per-square-unit parameter with a power-to-weight-ratio parameter. However, the manner in which these two parameters are combined is original logic and the result is an application as a vehicle weight efficiency index value.

Abstract: An antiviral composition has a supply of a chelating agent that chelates an alkaline earth metal ion, wherein the chelating agent is formulated in a rectal deposition formulation, and wherein the supply of chelating agent has an immediate bioavailability. Contemplated agents when rectally administered to a subject in an effective dose in vivo promote disintegration of a virus, reduction of atherosclerotic plaques and help reducing heavy metal concentration in a subject.

Abstract: A pharmacological composition comprises a synthetic reverse transcriptase inhibitor having a structure of a molecule that is present in a plant extract demonstrated to have an antiviral effect, wherein the molecule produces at least in part of the antiviral effect.

Abstract: A pharmacological composition comprises a reverse transcriptase inhibitor in a quantity sufficient to reduce a viral serum titer of a virus in an amount of at least 20% over a period of at least 6 hours, wherein preferred reverse transcriptase inhibitor comprise a plant extract.

Abstract: A pharmacological composition comprises an antiviral agent and a chelator in a quantity sufficient to reduce a serum concentration of a bivalent metal in an amount of at least 25%, wherein preferred antiviral agents include protease inhibitors, reverse transcriptase inhibitors, and/or an antibody, and wherein preferred chelators chelate at least one of Ca2+ and Mg2+.

Abstract: A pharmacological composition comprises a chelator in a time release formulation in a quantity sufficient to reduce a serum concentration of a bivalent metal in an amount of at least 20% for a period of at least 8 hrs. Preferred chelators chelate at least one of Ca2+ and Mg2+.

Abstract: A method of treating an HIV-related condition includes a step in which a patient is diagnosed as being infected with an HIV virus and having an HIV related condition. In a further step, a composition that comprises at least one of a chelator and an antiviral agent is administered to the patient, wherein the antiviral agent comprises a plant extract or a synthetic or isolated compound from a plant that is demonstrated to have an antiviral effect.